Published in PLoS One on December 16, 2016
Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother (2004) 7.99
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest (2002) 3.98
Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care (2008) 1.91
Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J (2006) 1.91
What is ventilator-associated pneumonia and why is it important? Respir Care (2005) 1.58
Impact of pathogen-directed antimicrobial therapy for ventilator-associated pneumonia in trauma patients on charges and recurrence. J Am Coll Surg (2014) 1.40
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management. Curr Opin Pulm Med (2013) 1.28
Carbapenemase-producing enterobacteriaceae in Spain in 2012. Antimicrob Agents Chemother (2013) 1.24
Multi-centre evaluation of real-time multiplex PCR for detection of carbapenemase genes OXA-48, VIM, IMP, NDM and KPC. BMC Infect Dis (2014) 1.22
Recommended design features of future clinical trials of antibacterial agents for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis (2010) 1.16
Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care (2009) 1.16
Prevalence and molecular epidemiology of acquired AmpC β-lactamases and carbapenemases in Enterobacteriaceae isolates from 35 hospitals in Spain. Eur J Clin Microbiol Infect Dis (2012) 1.14
The impact of ventilator-associated pneumonia on the Canadian health care system. J Crit Care (2008) 1.10
Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay. J Clin Microbiol (2013) 1.07
Antibacterial resistance leadership group: open for business. Clin Infect Dis (2014) 1.04
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs. Antimicrob Resist Infect Control (2013) 1.04
Rectal swabs are suitable for quantifying the carriage load of KPC-producing carbapenem-resistant Enterobacteriaceae. Antimicrob Agents Chemother (2013) 0.97
Multisite Evaluation of Cepheid Xpert Carba-R Assay for Detection of Carbapenemase-Producing Organisms in Rectal Swabs. J Clin Microbiol (2016) 0.97
Rapid detection of Staphylococcus aureus in lower respiratory tract secretions from patients with suspected ventilator-associated pneumonia: evaluation of the Cepheid Xpert MRSA/SA SSTI assay. J Clin Microbiol (2012) 0.96
Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia. Crit Care (2004) 0.95
Abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in Spain. J Med Microbiol (2012) 0.92
Cepheid Xpert MRSA cycle threshold in discordant colonization results and as a quantitative measure of nasal colonization burden. J Clin Microbiol (2012) 0.91
An unmet medical need: rapid molecular diagnostics tests for respiratory tract infections. Clin Infect Dis (2011) 0.89
Diagnostic yield of quantitative endotracheal aspirates in patients with severe nursing home-acquired pneumonia. Crit Care (2007) 0.88
[Diagnostic value of quantitative cultures of endotracheal aspirate in ventilator-associated pneumonia: a multicenter study]. Arch Bronconeumol (2003) 0.87
Conference summary: ventilator-associated pneumonia. Respir Care (2005) 0.85
Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii. Scand J Infect Dis (2014) 0.79
Moving towards real-time antimicrobial management of ventilator-associated pneumonia. Clin Infect Dis (2007) 0.78
Significant roadblocks exist in developing sputum sample libraries for clinical validation of novel in vitro diagnostics. Drug Des Devel Ther (2014) 0.77